Physician profile
Patrick J Caputo
NPI 1235190935
$1,153.07
in general payments reported to CMS, 2019-2025
12 companies · $46.79 in 2025
The $46.79 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $212 · 2022: $296 · 2023: $135 · 2024: $128 · 2025: $46.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.78 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $198.67 | 2019-2022 | |
| Horizon Therapeutics Plc | $167.50 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $155.23 | 2022-2025 | Nuzyra |
| Djo, LLC | $128.62 | 2019-2024 | Dr Comfort |
| Bard Peripheral Vascular, INC. | $125.54 | 2020 | |
| Integra Lifesciences Corporation | $93.33 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $71.51 | 2020-2022 | |
| Sebela Pharmaceuticals INC. | $54.52 | 2019-2023 | Naftin |
| Smith+Nephew, INC. | $47.81 | 2019-2022 | |
| Convatec INC. | $47.50 | 2023 | |
| Melinta Therapeutics, LLC | $43.21 | 2019 | |
| Paragon 28, INC. | $19.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Caputo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.